Skip to main content

Articles

Page 26 of 27

  1. Calcium is a key signaling ion involved in many different intracellular and extracellular processes ranging from synaptic activity to cell-cell communication and adhesion. The exact definition at the molecular...

    Authors: Philippe Marambaud, Ute Dreses-Werringloer and Valérie Vingtdeux
    Citation: Molecular Neurodegeneration 2009 4:20
  2. The γ-secretase complex is a major therapeutic target for the prevention and treatment of Alzheimer's disease. Previous studies have shown that treatment of young APP mice with specific inhibitors of γ-secreta...

    Authors: Monica Garcia-Alloza, Meenakshi Subramanian, Diana Thyssen, Laura A Borrelli, Abdul Fauq, Pritam Das, Todd E Golde, Bradley T Hyman and Brian J Bacskai
    Citation: Molecular Neurodegeneration 2009 4:19
  3. The low-density lipoprotein receptor-related protein 1 (LRP1) plays critical roles in lipid metabolism, cell survival, and the clearance of amyloid-β (Aβ) peptide. Functional soluble LRP1 (sLRP1) has been dete...

    Authors: Qiang Liu, Juan Zhang, Hien Tran, Marcel M Verbeek, Karina Reiss, Steven Estus and Guojun Bu
    Citation: Molecular Neurodegeneration 2009 4:17
  4. In AtT-20 cells ACTH secretion is regulated by both Ca2+ and G proteins. We previously demonstrated that calnuc, an EF-hand Ca2+ binding protein which regulates Alzheimer's β-amyloid precursor protein (APP) bioge...

    Authors: Ping Lin, Thierry Fischer, Christine Lavoie, Haining Huang and Marilyn Gist Farquhar
    Citation: Molecular Neurodegeneration 2009 4:15
  5. Accumulating evidence suggests that neurons prone to degeneration in Alzheimer's Disease (AD) exhibit evidence of re-entry into an aberrant mitotic cell cycle. Our laboratory recently demonstrated that, in a g...

    Authors: Kiran Bhaskar, Megan Miller, Alexandra Chludzinski, Karl Herrup, Michael Zagorski and Bruce T Lamb
    Citation: Molecular Neurodegeneration 2009 4:14
  6. Since the identification of tau as the main component of neurofibrillary tangles in Alzheimer's disease and related tauopathies, and the discovery that mutations in the tau gene cause frontotemporal dementia, ...

    Authors: Tania F Gendron and Leonard Petrucelli
    Citation: Molecular Neurodegeneration 2009 4:13
  7. Mutations in the DJ-1 gene have been linked to autosomal recessive familial Parkinson's disease. To understand the function of DJ-1, we determined the DJ-1 expression in both zebrafish and post mortem human br...

    Authors: Stéphanie Baulac, Hope Lu, Jennifer Strahle, Ting Yang, Matthew S Goldberg, Jie Shen, Michael G Schlossmacher, Cynthia A Lemere, Qun Lu and Weiming Xia
    Citation: Molecular Neurodegeneration 2009 4:12
  8. Expansion of a polyglutamine repeat at the amino-terminus of huntingtin is the probable cause for Huntington's disease, a lethal progressive autosomal-dominant neurodegenerative disorders characterized by impa...

    Authors: Andreas Weiss, Ana Roscic and Paolo Paganetti
    Citation: Molecular Neurodegeneration 2009 4:11
  9. Although there is a strong correlation between CAG repeat length and age at onset (AO) of motor symptoms, individual Huntington disease (HD) patients may differ dramatically in onset age and disease manifestat...

    Authors: Elahe Taherzadeh-Fard, Carsten Saft, Jürgen Andrich, Stefan Wieczorek and Larissa Arning
    Citation: Molecular Neurodegeneration 2009 4:10
  10. α-Synuclein is a small protein that has special relevance for understanding Parkinson disease and related disorders. Not only is α-synuclein found in Lewy bodies characteristic of Parkinson disease, but also m...

    Authors: Mark R Cookson
    Citation: Molecular Neurodegeneration 2009 4:9
  11. Midbrain dopaminergic neurons are involved in control of emotion, motivation and motor behavior. The loss of one of the subpopulations, substantia nigra pars compacta, is the pathological hallmark of one of th...

    Authors: Kambiz N Alavian and Horst H Simon
    Citation: Molecular Neurodegeneration 2009 4:6
  12. Gene microarray technology is an effective tool to investigate the simultaneous activity of multiple cellular pathways from hundreds to thousands of genes. However, because data in the colossal amounts generat...

    Authors: Wei Kong, Xiaoyang Mou, Qingzhong Liu, Zhongxue Chen, Charles R Vanderburg, Jack T Rogers and Xudong Huang
    Citation: Molecular Neurodegeneration 2009 4:5
  13. Huntington's disease (HD) is one of the most common autosomal dominant inherited, neurodegenerative disorders. It is characterized by progressive motor, emotional and cognitive dysfunction. In addition metabol...

    Authors: Patrick Weydt, Selma M Soyal, Cinzia Gellera, Stefano DiDonato, Claus Weidinger, Hannes Oberkofler, G Bernhard Landwehrmeyer and Wolfgang Patsch
    Citation: Molecular Neurodegeneration 2009 4:3
  14. The amyloid β-peptide is a ubiquitous peptide, which is prone to aggregate forming soluble toxic oligomers and insoluble less-toxic aggregates. The intrinsic and external/environmental factors that determine A...

    Authors: Alicia N Minniti, Daniela L Rebolledo, Paula M Grez, Ricardo Fadic, Rebeca Aldunate, Irene Volitakis, Robert A Cherny, Carlos Opazo, Colin Masters, Ashley I Bush and Nibaldo C Inestrosa
    Citation: Molecular Neurodegeneration 2009 4:2
  15. Activation of the liver × receptors (LXRs) by exogenous ligands stimulates the degradation of β-amyloid 1–42 (Aβ42), a peptide that plays a central role in the pathogenesis of Alzheimer's disease (AD). The oxi...

    Authors: Jaya RP Prasanthi, Amber Huls, Sarah Thomasson, Alex Thompson, Eric Schommer and Othman Ghribi
    Citation: Molecular Neurodegeneration 2009 4:1
  16. Insulin degrading enzyme (IDE) is implicated in the regulation of amyloid β (Aβ) steady-state levels in the brain, and its deficient expression and/or activity may be a risk factor in sporadic Alzheimer's dise...

    Authors: Ayelén Bulloj, María C Leal, Ezequiel I Surace, Xue Zhang, Huaxi Xu, Maria D Ledesma, Eduardo M Castaño and Laura Morelli
    Citation: Molecular Neurodegeneration 2008 3:22
  17. Parkinson's disease, the most common adult neurodegenerative movement disorder, demonstrates a brain-wide pathology that begins pre-clinically with alpha-synuclein aggregates ("Lewy neurites") in processes of ...

    Authors: M Kathleen Borland, Patricia A Trimmer, Jeremy D Rubinstein, Paula M Keeney, KP Mohanakumar, Lei Liu and James P Bennett Jr
    Citation: Molecular Neurodegeneration 2008 3:21
  18. Mutations in the presenilin (PSEN) genes are associated with early-onset familial Alzheimer's disease (FAD). Biochemical characterizations and comparisons have revealed that many PSEN mutations alter γ-secretase ...

    Authors: Chera L Maarouf, Ian D Daugs, Salvatore Spina, Ruben Vidal, Tyler A Kokjohn, R Lyle Patton, Walter M Kalback, Dean C Luehrs, Douglas G Walker, Eduardo M Castaño, Thomas G Beach, Bernardino Ghetti and Alex E Roher
    Citation: Molecular Neurodegeneration 2008 3:20
  19. Overexpression of α-synuclein (SNCA) in families with multiplication mutations causes parkinsonism and subsequent dementia, characterized by diffuse Lewy Body disease post-mortem. Genetic variability in SNCA cont...

    Authors: Jada Lewis, Heather Melrose, David Bumcrot, Andrew Hope, Cynthia Zehr, Sarah Lincoln, Adam Braithwaite, Zhen He, Sina Ogholikhan, Kelly Hinkle, Caroline Kent, Ivanka Toudjarska, Klaus Charisse, Ravi Braich, Rajendra K Pandey, Michael Heckman…
    Citation: Molecular Neurodegeneration 2008 3:19
  20. Chondroitin sulphate proteoglycan (NG2) expressing cells, morphologically characterized by multi-branched processes and small cell bodies, are the 4th commonest cell population of non-neuronal cell type in the ce...

    Authors: Ya Jun Wu, Ya Fang Tang, Zhi Cheng Xiao, Zhen Min Bao and Bei Ping He
    Citation: Molecular Neurodegeneration 2008 3:18
  21. Transcriptional dysregulation is an early, key pathogenic mechanism in Huntington's disease (HD). Therefore, gene expression analyses have biomarker potential for measuring therapeutic efficacy in pre-clinical...

    Authors: Caroline L Benn, Helen Fox and Gillian P Bates
    Citation: Molecular Neurodegeneration 2008 3:17
  22. The multifunctional protein vitronectin is present within the deposits associated with Alzheimer disease (AD), age-related macular degeneration (AMD), atherosclerosis, systemic amyloidoses, and glomerulonephri...

    Authors: Thuzar M Shin, J Mario Isas, Chia-Ling Hsieh, Rakez Kayed, Charles G Glabe, Ralf Langen and Jeannie Chen
    Citation: Molecular Neurodegeneration 2008 3:16
  23. Dimebon is an antihistamine compound with a long history of clinical use in Russia. Recently, Dimebon has been proposed to be useful for treating neurodegenerative disorders. It has demonstrated efficacy in ph...

    Authors: Jun Wu, Qin Li and Ilya Bezprozvanny
    Citation: Molecular Neurodegeneration 2008 3:15
  24. Familial Alzheimer's disease-linked variants of presenilin (PSEN1 and PSEN2) contribute to the pathophysiology of disease by both gain-of-function and loss-of-function mechanisms. Deletions of PSEN1 and PSEN2 in ...

    Authors: Károly Mirnics, Eric M Norstrom, Krassimira Garbett, Se Hoon Choi, Xiaoqiong Zhang, Philip Ebert and Sangram S Sisodia
    Citation: Molecular Neurodegeneration 2008 3:14
  25. Alzheimer disease (AD) is a chronic neurodegenerative disease that is characterized by progressive memory loss. Pathological markers of AD include neurofibrillary tangles, accumulation of amyloid-β plaques, ne...

    Authors: Kathryn J Bryan, Xiongwei Zhu, Peggy L Harris, George Perry, Rudy J Castellani, Mark A Smith and Gemma Casadesus
    Citation: Molecular Neurodegeneration 2008 3:13
  26. Regulated intramembrane proteolysis of the β-amyloid precursor protein by the γ-secretase yields two peptides. One, amyloid-β, is the major component of the amyloid plaques found in Alzheimer's disease patient...

    Authors: Luca Giliberto, Dawang Zhou, Richard Weldon, Elena Tamagno, Pasquale De Luca, Massimo Tabaton and Luciano D'Adamio
    Citation: Molecular Neurodegeneration 2008 3:12
  27. A number of studies have shown that increased APP levels, resulting from either a genomic locus duplication or alteration in APP regulatory sequences, can lead to development of early-onset dementias, including A...

    Authors: Neha Patel, David Hoang, Nathan Miller, Sara Ansaloni, Qihong Huang, Jack T Rogers, Jeremy C Lee and Aleister J Saunders
    Citation: Molecular Neurodegeneration 2008 3:10
  28. Abnormalities of microtubule-associated protein tau play a central role in neurofibrillary degeneration in several neurodegenerative disorders that collectively called tauopathies. Six isoforms of tau are expr...

    Authors: Fei Liu and Cheng-Xin Gong
    Citation: Molecular Neurodegeneration 2008 3:8
  29. Experimental autoimmune encephalomyelitis (EAE) is commonly used to investigate mechanisms of autoimmune-mediated damage to oligodendrocytes, myelin, and axons in multiple sclerosis (MS). Four distinct autoimm...

    Authors: Dusanka S Skundric, Rujuan Dai, Vaagn L Zakarian and Weili Zhou
    Citation: Molecular Neurodegeneration 2008 3:7
  30. Presenilin (PS1 or PS2) is an essential component of the active γ-secretase complex that liberates the Aβ peptides from amyloid precursor protein (APP). PS1 is regarded as an atypical aspartyl protease harbori...

    Authors: Donald B Carter, Edwige Dunn, Adele M Pauley, Denise D McKinley, Timothy J Fleck, Brenda R Ellerbrook, Nancy C Stratman, Xiangdong Zhou, Carol S Himes, Jeffrey S Nye, Alfredo Tomasselli and Riqiang Yan
    Citation: Molecular Neurodegeneration 2008 3:6
  31. Evidence from biochemical, epidemiological and genetic findings indicates that cholesterol levels are linked to amyloid-β (Aβ) production and Alzheimer's disease (AD). Oxysterols, which are cholesterol-derived...

    Authors: Celina V Zerbinatti, Joanna M Cordy, Ci-Di Chen, Maria Guillily, Sokreine Suon, William J Ray, Guy R Seabrook, Carmela R Abraham and Benjamin Wolozin
    Citation: Molecular Neurodegeneration 2008 3:5
  32. Alterations in multiple cellular pathways contribute to the development of chronic neurodegeneration such as a sporadic Alzheimer's disease (AD). These, in turn, involve changes in gene expression, amongst whi...

    Authors: Qing Yan Liu, Joy X Lei, Marianna Sikorska and Rugao Liu
    Citation: Molecular Neurodegeneration 2008 3:4
  33. Parkinson's disease (PD) is the most prevalent incurable neurodegenerative movement disorder. Mutations in LRRK2 are associated with both autosomal dominant familial and sporadic forms of PD. LRRK2 encodes a larg...

    Authors: Danling Wang, Beisha Tang, Guohua Zhao, Qian Pan, Kun Xia, Rolf Bodmer and Zhuohua Zhang
    Citation: Molecular Neurodegeneration 2008 3:3
  34. Shedding of the Alzheimer amyloid precursor protein (APP) ectodomain can be accelerated by phorbol esters, compounds that act via protein kinase C (PKC) or through unconventional phorbol-binding proteins such ...

    Authors: Annat F Ikin, Mirsada Causevic, Steve Pedrini, Lyndsey S Benson, Joseph D Buxbaum, Toshiharu Suzuki, Simon Lovestone, Shigeki Higashiyama, Tomas Mustelin, Robert D Burgoyne and Sam Gandy
    Citation: Molecular Neurodegeneration 2007 2:23
  35. The pathogenesis of Alzheimer's disease is highly complex. While several pathologies characterize this disease, amyloid plaques, composed of the β-amyloid peptide are hallmark neuropathological lesions in Alzh...

    Authors: Sarah L Cole and Robert Vassar
    Citation: Molecular Neurodegeneration 2007 2:22
  36. Mice carrying the spontaneous genetic mutation known as Wallerian degeneration slow (Wld s ) have a unique neuroprotective phenotype, where axonal and synaptic compartments o...

    Authors: Thomas M Wishart, Stephen HF MacDonald, Philip E Chen, Michael J Shipston, Michael P Coleman, Thomas H Gillingwater and Richard R Ribchester
    Citation: Molecular Neurodegeneration 2007 2:21
  37. Recent studies demonstrate that in addition to its modulatory effect on APP processing, in vivo application of Liver X Receptor agonist T0901317 (T0) to APP transgenic and non-transgenic mice decreases the level ...

    Authors: Iliya Lefterov, Angie Bookout, Zhu Wang, Matthias Staufenbiel, David Mangelsdorf and Radosveta Koldamova
    Citation: Molecular Neurodegeneration 2007 2:20
  38. Genetically engineered neural stem cell (NSC) lines are promising vectors for the treatment of neurodegenerative diseases, particularly Parkinson's disease (PD). Neurturin (NTN), a member of the glial cell lin...

    Authors: Wei-Guo Liu, Xi-Jing Wang, Guo-Qiang Lu, Biao Li, Gang Wang and Sheng-Di Chen
    Citation: Molecular Neurodegeneration 2007 2:19

    The Retraction Note to this article has been published in Molecular Neurodegeneration 2009 4:45

  39. Amyloid-related degenerative diseases are associated with the accumulation of misfolded proteins as amyloid fibrils in tissue. In Alzheimer disease (AD), amyloid accumulates in several distinct types of insolu...

    Authors: Rakez Kayed, Elizabeth Head, Floyd Sarsoza, Tommy Saing, Carl W Cotman, Mihaela Necula, Lawrence Margol, Jessica Wu, Leonid Breydo, Jennifer L Thompson, Suhail Rasool, Tatyana Gurlo, Peter Butler and Charles G Glabe
    Citation: Molecular Neurodegeneration 2007 2:18
  40. Alzheimer's disease (AD) is characterized by the presence of two histopathological hallmarks; the senile plaques, or extracellular deposits mainly composed of amyloid-β peptide (Aβ), and the neurofibrillary ta...

    Authors: Ismael Santa-Maria, Félix Hernández, Joaquín Del Rio, Francisco J Moreno and Jesús Avila
    Citation: Molecular Neurodegeneration 2007 2:17
  41. The strain of MeCP2tm1.1Bird mice is a broadly used model for Rett syndrome. Because males carrying the invalidated MeCP2 locus are sterile, this strain has to be maintained in a heterozygous state. All animals t...

    Authors: Julie Miralvès, Eddy Magdeleine and Etienne Joly
    Citation: Molecular Neurodegeneration 2007 2:16